<DOC>
	<DOCNO>NCT00413023</DOCNO>
	<brief_summary>The purpose study ass efficacy , safety tolerability GW679769 patient Major depressive Disorder ( MDD ) .</brief_summary>
	<brief_title>Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder ( MDD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<criteria>Inclusion criterion : Primary diagnosis Major depressive Disorder define DSMIV . Capable give informed consent willing comply study requirement . Women childbearing potential must agree one number define acceptable method birth control . Primary diagnosis within past 6 month another Axis 1 disorder anxiety disorder . Use medication psychiatric condition include herbal past 212 week accord medication type . Subjects , investigator 's judgement , pose current , serious suicidal homicidal risk make suicide attempt within past 6 month . Subjects currently meet meet within 6 month prior screen DSMIV criterion substance abuse subject currently meet meet within 6 month prior screen DSMIV criterion substance dependence ( nicotine ) . Significantly abnormal blood urine laboratory test electrocardiogram ( ECG ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>depression</keyword>
	<keyword>major depressive disorder</keyword>
	<keyword>MDD</keyword>
</DOC>